ESTIMATED
05/14/2024
05/14/2024
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.39 | -$0.39 | -$0.39 |
Q2 2024 | 1 | -$0.42 | -$0.42 | -$0.42 |
Q3 2024 | 0 | -$0.40 | -$0.40 | -$0.40 |
Q4 2024 | 0 | -$0.39 | -$0.39 | -$0.39 |
MAIA Biotechnology, Inc. last posted its earnings results on Tuesday, May 14th, 2024. The company reported $-0.46 earnings per share for the quarter, missing analysts' consensus estimates of $-0.33 by $0.13. The company had revenue of 0 for the quarter and had revenue of 0 for the year. MAIA Biotechnology, Inc. has generated $-1 earnings per share over the last year ($-1.49 diluted earnings per share) and currently has a price-to-earnings ratio of -2.47. MAIA Biotechnology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 19th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/14/2024 | Q1 2024 | -$0.33 | -$0.46 | -0.13 | $0 | $0 | 03/21/2024 | Q4 2023 | -$0.35 | -$0.37 | -0.02 | $0 | 11/07/2023 | Q3 2023 | -$0.36 | $0 | $0 | 08/08/2023 | Q2 2023 | -$0.43 | -$0.35 | 0.08 | $0 | 05/08/2023 | Q1 2023 | -$0.40 | -$0.37 | 0.03 | $0 | 03/24/2023 | Q4 2022 | -$0.41 | -$0.44 | -0.03 | $0 | 11/09/2022 | Q3 2022 | -$0.49 | $0 | 08/22/2022 | Q2 2022 | -$0.31 | $0 | 03/30/2022 | Q1 2022 | -$0.32 | $0 | 12/31/2021 | Q4 2021 | $0.00 | $0 | 09/30/2021 | Q3 2021 | -$0.49 | $0 | 06/30/2021 | Q2 2021 | -$0.32 | $0 | 03/30/2021 | Q1 2021 | -$0.09 | $0 |
---|
A. MAIA Biotechnology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 19th, 2024 based off last year's report dates.
A. The conference call for MAIA Biotechnology, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for MAIA Biotechnology, Inc.'s latest earnings report can be read online.
A. MAIA Biotechnology, Inc. (AMEX:MAIA) has a recorded net income of $0. MAIA Biotechnology, Inc. has generated $-1.49 earnings per share over the last four quarters.
A. MAIA Biotechnology, Inc. (AMEX:MAIA) has a price-to-earnings ratio of -2.47 and price/earnings-to-growth ratio is -0.2.